Sammen med alvorlig neutropeni forekom der feber eller infektion hos 16% af patienterne under kur 1 og totalt set hos 23% af patienterne (6% af behandlingerne).
In association with severe neutropenia, fever or infection occurred in 16% of patients during course 1 and overall in 23% of patients (6% of courses).